Clinical trial
Prevention of CHOP-induced Chronic Cardiotoxicity
NCT00162955 · Osaka City University, Other · Completed
Key facts
| NCT number | NCT00162955 |
|---|---|
| Title | Prevention of CHOP-induced Chronic Cardiotoxicity |
| Official title | The Multi-centers Trial for Patients With Non-Hodgkin's Lymphoma to Assess the Protective Effect of Valsartan on Chronic Cardiotoxicity Induced by CHOP |
| Lead sponsor | Osaka City University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | Valsartan |
| Enrollment | 150 |
| Start date | May 1, 2004 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Sep 13, 2005 |
| Last update posted | May 8, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: